Resmed reported $262.26M in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abiomed ABMD:US $ 69.82M 4.94M
Ansell ANN:AU $ 155.12M 14.02M
Atricure ATRC:US $ -14.8M 0.33M
Cantel Medical CMN:US $ 46.2M 1.87M
Cardiovascular Systems CSII:US $ -9.64M 0.05M
Cryolife CRY:US $ -1.75M 3.16M
Edwards Lifesciences EW:US $ 451.1M 10.3M
Fisher Paykel Healthcare FPH:NZ 203.1M 98M
Idexx Laboratories IDXX:US $ 171.08M 70.41M
Inogen INGN:US $ -3.37M 10.62M
Insulet PODD:US $ -36.1M 65.4M
Medtronic MDT:US $ 1734M 611M
Resmed RMD:US $ 262.26M 17.23M
Sigma Healthcare Ltd SIG:AU $ 16.89M 4.46M